Division of Clinical and Metabolic Genetics.
Genetics and Genome Biology, Research Institute.
Am J Respir Crit Care Med. 2022 Apr 1;205(7):761-768. doi: 10.1164/rccm.202106-1456OC.
Mucin homeostasis is fundamental to airway health. Upregulation of airway mucus glycoprotein MUC5B is observed in diverse common lung diseases and represents a potential therapeutic target. In mice, Muc5b is required for mucociliary clearance and for controlling inflammation after microbial exposure. The consequences of its loss in humans are unclear. The goal of this study was to identify and characterize a family with congenital absence of MUC5B protein. We performed whole-genome sequencing in an adult proband with unexplained bronchiectasis, impaired pulmonary function, and repeated infection. Deep phenotyping over a 12-year period included assessments of pulmonary radioaerosol mucociliary clearance. Genotyping with reverse phenotyping was organized for eight family members. Extensive experiments, including immunofluorescence staining and mass spectrometry for mucins, were performed across accessible sample types. The proband, and her symptomatic sibling who also had extensive sinus disease with nasal polyps, were homozygous for a novel splicing variant in the gene (NM_002458.2: c.1938 + 1G>A). MUC5B was absent from saliva, sputum, and nasal samples. Mucociliary clearance was impaired in the proband, and large numbers of apoptotic macrophages were present in sputum. Three siblings heterozygous for the familial variant were asymptomatic but had a shared pattern of mild lung function impairments. Congenital absence of MUC5B defines a new category of genetic respiratory disease. The human phenotype is highly concordant with that of the murine model. Further study of individuals with decreased MUC5B production could provide unique mechanistic insights into airway mucus biology.
黏液动态平衡是气道健康的基础。在多种常见肺部疾病中观察到气道黏液糖蛋白 MUC5B 的上调,这代表了一个潜在的治疗靶点。在小鼠中,Muc5b 对于黏液纤毛清除和微生物暴露后控制炎症是必需的。其在人类中丧失的后果尚不清楚。本研究的目的是鉴定和表征一个先天性缺乏 MUC5B 蛋白的家族。我们对一名患有不明原因支气管扩张症、肺功能受损和反复感染的成年先证者进行了全基因组测序。在 12 年的时间里进行了深入的表型分析,包括对肺部放射性气溶胶黏液纤毛清除率的评估。对 8 名家族成员进行了反向表型的基因分型。对可及样本类型进行了广泛的实验,包括免疫荧光染色和黏蛋白的质谱分析。先证者及其有症状的同胞均为 基因(NM_002458.2:c.1938 + 1G>A)的一种新型剪接变异纯合子。唾液、痰和鼻样本中均缺乏 MUC5B。先证者的黏液纤毛清除功能受损,痰中存在大量凋亡的巨噬细胞。3 名杂合携带家族变异的同胞无症状,但有轻度肺功能受损的共同模式。先天性缺乏 MUC5B 定义了一种新的遗传性呼吸道疾病类别。人类表型与小鼠模型高度一致。对 MUC5B 产生减少的个体的进一步研究可能为气道黏液生物学提供独特的机制见解。